相关实验视频
Updated: Jun 22, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
皮肤黑色素瘤治疗中的未解决的挑战?
Alessia Villani1, Luca Potestio1, Aimilios Lallas2
1Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Medicina (Kaunas, Lithuania)
|June 27, 2024
概括
先进的黑色素瘤治疗正在发展,免疫检查点抑制剂和向疗法显示出承诺. 然而,对于耐药病例和特定黑色素瘤阶段,新的治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非侵入性皮肤黑色素瘤 (CM) 的管理通常涉及切除和随访.
- 晚期黑色素瘤带来了重大的治疗挑战.
- 目前的治疗方法包括免疫检查点抑制剂和向疗法.
研究的目的:
- 审查先进皮肤黑色素瘤的既定和新兴的药理策略.
- 为当前的治疗领域提供最新的洞察力.
- 讨论正在进行的关于新型治疗方式的调查.
主要方法:
- 对高级CM的药理学策略进行全面的文献综述.
- 免疫检查点抑制剂和向疗法 (单疗和组合疗法) 的分析.
- 探索新兴的治疗方式和正在进行的研究.
主要成果:
- 晚期黑色素瘤的治疗场景正在迅速转变.
- 已建立的疗法,如免疫检查点抑制剂和向药物,证明了其有效性.
- 对抗性黑色素瘤或特定阶段的新疗法仍然存在关键需求.
结论:
- 进一步的研究对于发现晚期黑色素瘤的新治疗途径至关重要.
- 优化现有的药物利用是必要的.
- 黑色素瘤管理的不断变化的性质需要持续调查.
相关概念视频
01:30Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
01:27Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K